Dr. Eric P. Kielhorn
Claim this profileProMedica Flower Hospital
Studies Nasopharyngeal Carcinoma
Studies EBV Infection
4 reported clinical trials
25 drugs studied
Area of expertise
1Nasopharyngeal Carcinoma
Stage II
Stage III
Stage IV
2EBV Infection
Stage II
Stage III
Stage IV
Affiliated Hospitals
Clinical Trials Eric P. Kielhorn is currently running
Lomustine + Standard Therapy
for Glioblastoma
This phase III trial compares the effect of adding lomustine to temozolomide and radiation therapy versus temozolomide and radiation therapy alone in shrinking or stabilizing newly diagnosed MGMT methylated glioblastoma. Chemotherapy drugs, such as lomustine and temozolomide, work in different ways to stop the growth of tumor cells, either by killing the cells, by stopping them from dividing, or by stopping them from spreading. Radiation therapy uses high energy photons to kill tumor cells and shrink tumors. Adding lomustine to usual treatment of temozolomide and radiation therapy may help shrink and stabilize glioblastoma.
Recruiting2 awards Phase 34 criteria
Hormone + Radiation Therapy
for Prostate Cancer
This phase III trial compares less intense hormone therapy and radiation therapy to usual hormone therapy and radiation therapy in treating patients with high risk prostate cancer and low gene risk score. This trial also compares more intense hormone therapy and radiation therapy to usual hormone therapy and radiation therapy in patients with high risk prostate cancer and high gene risk score. Apalutamide may help fight prostate cancer by blocking the use of androgen by the tumor cells. Radiation therapy uses high energy rays to kill tumor cells and shrink tumors. Giving a shorter hormone therapy treatment may work the same at controlling prostate cancer compared to the usual 24 month hormone therapy treatment in patients with low gene risk score. Adding apalutamide to the usual treatment may increase the length of time without prostate cancer spreading as compared to the usual treatment in patients with high gene risk score.
Recruiting2 awards Phase 36 criteria
More about Eric P. Kielhorn
Clinical Trial Related2 years of experience running clinical trials · Led 4 trials as a Principal Investigator · 3 Active Clinical TrialsTreatments Eric P. Kielhorn has experience with
- Cisplatin
- Fluorouracil
- Gemcitabine Hydrochloride
- Paclitaxel
- Intensity-Modulated Radiation Therapy
- Radiation
Breakdown of trials Eric P. Kielhorn has run
Nasopharyngeal Carcinoma
Nasopharyngeal Cancer
Other Doctors you might be interested in
Frequently asked questions
Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the ‘trial drug’ — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
What does Eric P. Kielhorn specialize in?
Eric P. Kielhorn focuses on Nasopharyngeal Carcinoma and EBV Infection. In particular, much of their work with Nasopharyngeal Carcinoma has involved Stage II patients, or patients who are Stage III.
Is Eric P. Kielhorn currently recruiting for clinical trials?
Yes, Eric P. Kielhorn is currently recruiting for 3 clinical trials in Sylvania Ohio. If you're interested in participating, you should apply.
Are there any treatments that Eric P. Kielhorn has studied deeply?
Yes, Eric P. Kielhorn has studied treatments such as Cisplatin, Fluorouracil, Gemcitabine Hydrochloride.
What is the best way to schedule an appointment with Eric P. Kielhorn?
Apply for one of the trials that Eric P. Kielhorn is conducting.
What is the office address of Eric P. Kielhorn?
The office of Eric P. Kielhorn is located at: ProMedica Flower Hospital, Sylvania, Ohio 43560 United States. This is the address for their practice at the ProMedica Flower Hospital.
Is there any support for travel costs?
The coverage of travel expenses can vary greatly between different clinical trials. Please see more financial detail in the trials you’re interested to apply.